Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
935.4000 2.85 (0.31%)
NSE Dec 03, 2025 15:31 PM
Volume: 2.0M
 

logo
Natco Pharma Ltd.
08 Aug 2017
935.40
0.31%
buy
Results Update: Natco Pharma Ltd.
by HDFC Securities
HDFC Securities
Revenue decreased by 25.91% to Rs. 428.1 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 25.91% to Rs. 428.1 Cr in Q1FY18 when compared to the previous quarter.
 
Natco Pharma Ltd. has an average target of 845.00 from 2 brokers.
More from Natco Pharma Ltd.
Recommended
Market closes lower as the rupee hits an all-time low
Trendlyne Marketwatch | 03 Dec 2025, 03:59PM
Could Rs 90 per dollar be good for India?
The Baseline | 03 Dec 2025, 12:23PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
| 18 Jun 2020